Chimerix (CMRX) Q2 2022 Earnings Call Transcript

Chimerix (CMRX) Q2 2022 Earnings Call Transcript

With me on today's call are president and chief executive officer, Mike Sherman; chief medical officer, Allen Melemed; chief financial and business officer, Mike Andriole; chief science officer, Randall Lanier; and our chief technology officer of Imipridones, Josh Allen. Before we begin, I'd like to remind you that the statements made on today's call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties and other factors.